Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Solutions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Neoplasms 1 Pain 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Keratosis, Actinic 1 Hemorrhage 1 Haloperidol 1 Growth Hormone-Secreting Pituitary Adenoma 1 Brain Neoplasms 1 Anemia 1 Acromegaly 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Morphine 6 Ibandronic Acid 6 nabiximols 5 Ketamine 5 Hydromorphone 5 Analgesia 5 Tapentadol 4 Oxycodone 4 Acetaminophen 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 Acupuncture Therapy 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01836328 2016-03-16

RATIOMTD

L'Hospitalet de Llobregat

Phase 3 Completed

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡